Swedbank AB increased its position in shares of CVS Health Co. (NYSE:CVS - Free Report) by 1.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,405,812 shares of the pharmacy operator's stock after buying an additional 16,923 shares during the period. Swedbank AB owned 0.11% of CVS Health worth $63,107,000 as of its most recent filing with the SEC.
A number of other large investors have also modified their holdings of CVS. Farmers National Bank raised its stake in shares of CVS Health by 5.9% during the 2nd quarter. Farmers National Bank now owns 97,817 shares of the pharmacy operator's stock worth $5,777,000 after buying an additional 5,453 shares during the period. Strategic Investment Solutions Inc. IL purchased a new position in CVS Health during the second quarter valued at $63,000. Brown Financial Advisors purchased a new stake in shares of CVS Health during the second quarter worth about $684,000. Sanctuary Advisors LLC acquired a new position in shares of CVS Health during the 2nd quarter worth about $8,005,000. Finally, Prio Wealth Limited Partnership boosted its holdings in CVS Health by 1.1% in the 2nd quarter. Prio Wealth Limited Partnership now owns 57,413 shares of the pharmacy operator's stock worth $3,391,000 after buying an additional 600 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.
Wall Street Analyst Weigh In
Several equities analysts have recently weighed in on CVS shares. UBS Group raised their target price on CVS Health from $60.00 to $62.00 and gave the company a "neutral" rating in a research report on Thursday, November 7th. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a "hold" rating to a "buy" rating and set a $66.00 target price for the company in a research report on Tuesday, December 3rd. Royal Bank of Canada dropped their price objective on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating for the company in a research note on Friday, November 15th. StockNews.com lowered CVS Health from a "hold" rating to a "sell" rating in a research note on Thursday, November 14th. Finally, Piper Sandler cut their price objective on shares of CVS Health from $72.00 to $64.00 and set an "overweight" rating for the company in a research report on Monday, November 25th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, CVS Health currently has an average rating of "Moderate Buy" and a consensus target price of $68.12.
Get Our Latest Stock Report on CVS
CVS Health Stock Down 0.5 %
Shares of CVS stock traded down $0.31 during trading on Thursday, reaching $56.59. The company's stock had a trading volume of 5,510,166 shares, compared to its average volume of 13,215,415. The company has a market capitalization of $71.21 billion, a price-to-earnings ratio of 14.37, a P/E/G ratio of 0.80 and a beta of 0.59. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The stock's 50-day moving average price is $51.28 and its 200 day moving average price is $56.17.
CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts' consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same quarter in the prior year, the company earned $2.21 earnings per share. The company's revenue was up 6.3% on a year-over-year basis. On average, research analysts anticipate that CVS Health Co. will post 5.22 EPS for the current year.
CVS Health Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be paid a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.70%. CVS Health's payout ratio is 67.51%.
CVS Health Company Profile
(
Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
See Also
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.